His main research concerns Proteomics, Bioinformatics, Mass spectrometry, Computational biology and Proteome. His Proteomics research is multidisciplinary, incorporating elements of Systems biology, Phosphorylation, Reproducibility, Biomarker and Kinase. His biological study spans a wide range of topics, including Quantitative proteomics, Biomarker discovery, Targeted mass spectrometry, Extracellular matrix and In silico.
The various areas that he examines in his Computational biology study include Genome, Serous fluid, Ovarian cancer, Breast cancer and Chromosome instability. The Proteome study combines topics in areas such as Gene dosage, Proteogenomics, Gene and Function. His research in Chromatography intersects with topics in Peptide sequence and Peptide.
Steven A. Carr focuses on Proteomics, Cell biology, Computational biology, Cancer research and Mass spectrometry. His Proteomics study incorporates themes from Proteome, Bioinformatics and Proteogenomics. His research brings together the fields of Translation and Cell biology.
Steven A. Carr combines subjects such as Gene and Genomics with his study of Computational biology. His Cancer research research integrates issues from Cancer cell, Cancer, Kinase, Extracellular matrix and Ubiquitin ligase. His studies in Mass spectrometry integrate themes in fields like Biochemistry and Peptide.
Steven A. Carr mainly investigates Cancer research, Cell biology, Proteomics, Computational biology and Proteome. His Cancer research research includes elements of Carcinogenesis, Cancer, Immune system, Kinase and Ubiquitin ligase. The study incorporates disciplines such as Gene expression, Biotinylation, Transcription factor, Mutant and Ribosome in addition to Cell biology.
The subject of his Proteomics research is within the realm of Gene. As part of one scientific family, Steven A. Carr deals mainly with the area of Computational biology, narrowing it down to issues related to the Epitope, and often Cancer immunotherapy and Human leukocyte antigen. His Proteome study combines topics in areas such as Proteomic Profiling, Enzyme, Viral replication, Interactome and Peptide.
Proteomics, Computational biology, Proteome, Cancer research and Cell biology are his primary areas of study. His studies deal with areas such as Cancer cell, Proteogenomics, Serous fluid and Multicellular organism as well as Proteomics. His Computational biology research incorporates elements of PI3K/AKT/mTOR pathway and Phosphorylation.
The concepts of his Proteome study are interwoven with issues in Interlaboratory reproducibility, Time course, Proteomic Profiling, Epitope and Peptide. Steven A. Carr has researched Cancer research in several fields, including Extracellular matrix, Mitochondrion, Immune system and Lymphoma. His Cell biology research includes themes of Homeobox, Loss function, CRISPR, RNA and Interactome.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Orexins and Orexin Receptors: A Family of Hypothalamic Neuropeptides and G Protein-Coupled Receptors that Regulate Feeding Behavior
Takeshi Sakurai;Akira Amemiya;Makoto Ishii;Ichiyo Matsuzaki.
The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease
Justin Lamb;Emily D. Crawford;David Peck;Joshua W. Modell.
Protein biomarker discovery and validation: the long and uncertain path to clinical utility.
Nader Rifai;Michael A Gillette;Steven A Carr.
Nature Biotechnology (2006)
A Mitochondrial Protein Compendium Elucidates Complex I Disease Biology
David J. Pagliarini;Sarah E. Calvo;Betty Chang;Sunil A. Sheth.
Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells
Jan Krönke;Namrata D. Udeshi;Anupama Narla;Peter Grauman.
Proteogenomics connects somatic mutations to signalling in breast cancer
Philipp Mertins;D. R. Mani;Kelly V. Ruggles;Michael A. Gillette;Michael A. Gillette.
Proteogenomic characterization of human colon and rectal cancer
Bing Zhang;Jing Wang;Xiaojing Wang;Jing Zhu.
Multi-site assessment of the precision and reproducibility of multiple reaction monitoring–based measurements of proteins in plasma
Terri A. Addona;Susan E. Abbatiello;Birgit Schilling;Steven J. Skates.
Nature Biotechnology (2009)
Selective killing of cancer cells by a small molecule targeting the stress response to ROS
Lakshmi Raj;Takao Ide;Aditi U. Gurkar;Michael Foley.
PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase.
Yasemin Sancak;Carson C. Thoreen;Timothy R. Peterson;Robert A. Lindquist.
Molecular Cell (2007)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: